KY
Keda Yang
Principal Investigator
Zhejiang Shuren University
I'm working on
9 months ago
Biomedical AI, Drug Discovery Platforms, Biomaterials, Biosensors
About
Bridges biomedical AI, biomaterials, and biosensing. Co-developed MolProphet, a drug discovery platform with 400+ users. Focus on clinical ML, few-shot molecular modeling, shape‑memory polymers, and nanomaterial safety.
Partnering listings
Learn more
Zhejiang Shuren University
AI-Powered Drug Discovery Platform for Rapid 5 Alpha Reductase Inhibitor Identification
Computational drug discovery platform combining structure-based screening, AI molecular generation, and optimization to rapidly identify 5 alpha reductase inhibitor lead compounds. Reduces time and cost of early-stage dr...
TechnologyUniversity
Zhejiang Shuren University
Live Attenuated Intranasal Feline Core Vaccine for FPV, FCV, and FHV-1
A nasal-delivered, live-attenuated vaccine targeting three core feline viruses (feline panleukopenia virus, feline calicivirus, and feline herpesvirus-1). This approach avoids chronic kidney disease risks linked to injec...
TechnologyConceptualUniversity
Zhejiang Shuren University
Platform and library for bifunctional molecule design
Bifunctional molecule design platform used by over 400 users for new drug design. Demonstrated effectiveness in Protein-Protein Interaction inhibitors with future validation plans including AI and molecular dynamics simu...
TechnologyIn developmentUniversity
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.